“Drug Drug Interaction Risk in COVID-19 Management – The Issue to be Addressed”, Sir Salimullah Med. Coll. J., vol. 29, no. 2, pp. 85–86, Apr. 2022, doi: 10.3329/ssmcj.v29i2.58851.